Clin Exp Otorhinolaryngol.  2024 May;17(2):116-121. 10.21053/ceo.2023.00017.

Positive Airway Pressure Therapy Compliance in Patients With Comorbid Insomnia and Sleep Apnea

• Bae MR
• Lee YH
• Lee SW
• Chung S
• Chung YS

• KMID: 2556002
• DOI: http://doi.org/10.21053/ceo.2023.00017

Abstract

Objectives
. This study aimed to compare positive airway pressure (PAP) therapy compliance between patients with comorbid insomnia and sleep apnea (COMISA) and those with obstructive sleep apnea (OSA) alone. It also assessed the influence of insomnia clinic visits on PAP compliance.
Methods
. Patients diagnosed with OSA and initiated on PAP therapy between January 2012 and December 2021 were included. The COMISA group (n=43) comprised patients with insomnia, while the control group (n=86) consisted of OSA patients without insomnia, matched 1:2 based on age and sex. COMISA patients were further categorized into group A (n=20), with at least two insomnia clinic visits, and group B (n=23) with one or no visits. PAP compliance in each group was evaluated at 3 and 9 months.
Results
. No significant differences were observed in PAP compliance between the COMISA patients and OSA patients without insomnia. Within the COMISA group, the impact of insomnia clinic visits on PAP compliance was not significant. No significant difference was observed in daily PAP usage between the two groups at 3 months (265.5±145.9 minutes in group A vs. 236.3±152.3 minutes in group B, P=0.760) or 9 months (213.4±155.3 minutes in group A vs. 166.3±158.3 minutes in group B, P=0.538). The percentages of PAP users and nights with PAP use exceeding 4 hours also showed no significant differences at either time point.
Conclusion
. This study demonstrated no significant disparity in PAP compliance between the COMISA and OSA groups at either 3 or 9 months. Furthermore, insomnia clinic visits did not significantly impact PAP compliance in COMISA patients during 3- and 9-month intervals.

Keyword

Positive Airway Pressure; Compliance; Insomnia; Obstructive Sleep Apnea; Comorbid Insomnia and Sleep Apnea

Reference

1. Guilleminault C, Eldridge FL, Dement WC. Insomnia with sleep apnea: a new syndrome. Science. 1973; Aug. 181(4102):856–8.

2. Chung KF. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration. 2005; Sep-Oct. 72(5):460–5.

3. Cronlein T, Geisler P, Langguth B, Eichhammer P, Jara C, Pieh C, et al. Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath. 2012; Dec. 16(4):1097–103.

4. Sweetman AM, Lack LC, Catcheside PG, Antic NA, Chai-Coetzer CL, Smith SS, et al. Developing a successful treatment for co-morbid insomnia and sleep apnoea. Sleep Med Rev. 2017; Jun. 33:28–38.

5. Wickwire EM, Smith MT, Birnbaum S, Collop NA. Sleep maintenance insomnia complaints predict poor CPAP adherence: a clinical case series. Sleep Med. 2010; Sep. 11(8):772–6.

6. Pieh C, Bach M, Popp R, Jara C, Cronlein T, Hajak G, et al. Insomnia symptoms influence CPAP compliance. Sleep Breath. 2013; Mar. 17(1):99–104.

7. Lack L, Sweetman A. Diagnosis and treatment of insomnia comorbid with obstructive sleep apnea. Sleep Med Clin. 2016; Sep. 11(3):379–88.

8. Bjornsdottir E, Janson C, Sigurdsson JF, Gehrman P, Perlis M, Juliusson S, et al. Symptoms of insomnia among patients with obstructive sleep apnea before and after two years of positive airway pressure treatment. Sleep. 2013; Dec. 36(12):1901–9.

9. Sweetman A, Lack L, Catcheside PG, Antic NA, Smith S, Chai-Coetzer CL, et al. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep. 2019; Dec. 42(12):zsz178.

10. Alessi CA, Fung CH, Dzierzewski JM, Fiorentino L, Stepnowsky C, Rodriguez Tapia JC, et al. Randomized controlled trial of an integrated approach to treating insomnia and improving the use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apnea. Sleep. 2021; Apr. 44(4):zsaa235.

11. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020; Apr. 323(14):1389–400.

12. Nguyen XL, Chaskalovic J, Rakotonanahary D, Fleury B. Insomnia symptoms and CPAP compliance in OSAS patients: a descriptive study using Data Mining methods. Sleep Med. 2010; Sep. 11(8):777–84.

13. Cho YW, Kim KT, Moon HJ, Korostyshevskiy VR, Motamedi GK, Yang KI. Comorbid insomnia with obstructive sleep apnea: clinical characteristics and risk factors. J Clin Sleep Med. 2018; Mar. 14(3):409–17.

14. Ong JC, Crawford MR, Wallace DM. Sleep apnea and insomnia: emerging evidence for effective clinical management. Chest. 2021; May. 159(5):2020–8.

15. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; Jul. 333(7557):15.